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and Hep-2C derive from the same tis-
sue (human Caucasian larynx carcino-
ma), while Vero and BGM derive
from another organ (Africa green
monkey kidney). Thus, Hep-2 and
Vero cell lines that we used are likely
susceptible to TSV if the virus can
infect Hep-2C and BGM as reported
by Audelo-del-Valle et al.
The difference between our meth-
ods and those used by Audelo-del-
Valle et al. may explain the discrepant
result. If CPE occurred “usually from
19–23 hours” and “cells were then
harvested and lysed” for next injec-
tion, TSV most likely persisted in the
lysate after the third passage because
the cell monolayers had not been
washed as they were in our method.
According to the time the CPE was
observed and the methods of Audelo-
del-Valle et al., we assumed that, in
their study, cells might be passaged at
least three times within 1 week,
whereas TSV might remain viable and
infective for 1 week. Additionally, the
Office International des Epizooties
recommended an injection volume of
1% of shrimp body weight (8);
Audelo-del-Valle et al. used 10%.
With such a large dose, shrimp could
be infected easily with TSV from the
initial medium and die suddenly.
Moreover, the evidence of successful
infection from photos of CPE only is
not sufficient; Audelo-del-Valle et al.
should offer more convincing evi-
dence from images of viral particles in
cells by electron microscope or in situ
hybridization. Therefore, we think the
CPE that Audelo-del-Valle et al.
reported was not caused by TSV but
by a virus contaminant or some harm-
ful component from shrimp extract.
The structure of the TSV genome
is similar to that of small
insect–infecting RNA viruses (10),
which belong to a renamed virus
genus, Cripavirus (11). No published
reports have shown that other viruses
in this genus are able to infect mam-
malian cells or cell lines. Moreover,
TSV is prevalent in shrimp farming
areas in the world, and L. vannamei
(principal host for TSV) are eaten by
people worldwide (8). In China, some
persons eat fresh shrimp without dis-
infecting them; however, no evidence
shows that TSV can infect humans.
The results of our study show that
TSV cannot infect mammalian cell
lines or cells.
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To the Editor: The genus Barton-
ella  contains several recently
described species, many of which are
emerging human pathogens. Human
infections are mostly due to Bartonella
henselae and B. quintana. Like many
vectorborne disease agents, Bartonella
species have a natural cycle. This cycle
contains a reservoir host, in which
Bartonella species cause an intraery-
throcytic bacteremia, and a vector,
which transmits the bacteria from the
reservoir host to a new susceptible host
(usually the uninfected reservoir host)
(1). In the case of B. quintana and B.
bacilliformis,  the natural host is
human. In Bartonella  diseases,
humans act as accidental hosts. Among
the nonhuman Bartonella species that
infect humans, B. henselae is most
commonly encountered and usually
causes cat-scratch disease. However,
several cases of infections in humans
attributable to other Bartonella
species, including B. elizabethae, B.
grahamii, B. vinsonii arupensis,  B.
vinsonii berkhoffii, and possibly B.
clarridgeiae, have been reported (1).LETTERS
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Isolation of Bartonella species in ani-
mals that have contact with humans
can help identify new human
pathogens or new diseases. We report
results of isolation of Bartonella spp.
from the blood of 258 dogs in Gabon.
The study was performed in the
Ogooué-Ivindo province of Gabon, a
country of Central Africa with an
equatorial climate. Blood samples
were taken from dogs in the town of
Mékambo and in all villages connect-
ing Mékambo and Mazingo (nine vil-
lages) and Mékambo and Ekata
(seven villages) during July and
August 2003. Each dog brought by its
owner for the study was weighed and
sedated by injection with 50 µg/kg of
medetomidine (Pfizer Santé Animal,
Orsay, France). After the dog was
examined, a blood sample was drawn
from the jugular vein by Vacutainer
(Becton Dickinson, Meylan, France).
Each dog was tattooed with an identi-
fication number and given both anti-
helminthic and external antiparasitic
treatments. During the examination,
the dogs were treated with care; upon
completion of the examination, the
dogs were given 250 µg/kg of the
reversal agent atipamezola (Pfizer
Santé Animal) intramuscularly. A
physical examination form and a
questionnaire were completed for
each test participant by its owner. A
total of 258 dogs (155 males and 103
females) were examined and had
blood samples drawn during the
study. All animals were of mixed
breeds and were 6 months to 14 years
old (average 3 years 1 month). The
Vacutainer tubes were kept on ice
until blood samples were dispensed
into cryotubes and frozen in liquid
nitrogen. Samples were stored at
–80°C until isolation attempts were
made on Columbia agar (Biomérieux,
Marcy l’étoile, France) as described
previously (2). In this study, six
Bartonella isolates were obtained and
identified as B. clarridgeiae (five iso-
lates) and B. henselae (one isolate), by
internal transcribed spacer amplifica-
tion and sequencing (3). 
B. vinsonii subsp.  berkhoffii  was
the first Bartonella species found in
dogs (1). Isolation of B. clarridgeiae
(4,5) and B. washoensis (6) in dogs
was recently reported. Infection of
dogs by other Bartonella species was
also detected in the DNA of B. hense-
lae (7,8), B. clarridgeiae (7), and B.
elizabethae (8). The presence of these
Bartonella species is not surprising,
since Ctenocephalides felis, the vector
of  B. henselae in cats, has a wide
range of hosts, including the domestic
dog. However, attempts to isolate this
species in samples collected from 211
dogs in the United Kingdom failed
(9). Bartonella species are supposedly
difficult to isolate in dogs because of
a low concentration of bacteria in the
blood (1). This supposition was
apparent in our study; we identified
approximately 100 bacterial colonies
per milliliter of blood from three of
the six dogs in our study. From the
other three dogs in our study, includ-
ing the dog infected with B. henselae,
we identified two to four bacterial
colonies per milliliter of blood.
Most of the data pertaining to
Bartonella have been obtained in the
United States and Europe.
Increasingly, Bartonella infections are
being reported in Africa, especially in
southern Africa (10). We report here
the first isolation of B. henselae from
a dog and the first isolation of B. clar-
ridgeiae in Central Africa. That dogs
also act as reservoirs of B. henselae
likely has implications in Africa
where HIV infections are prevalent.
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